Stuart T Perry
Overview
Explore the profile of Stuart T Perry including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
303
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Perry S, Keogh E, Morton M, Koudstaal W, Pascual G
J Vis Exp
. 2019 Sep;
(150).
PMID: 31498318
The human antibody repertoire represents a largely untapped source of potential therapeutic antibodies and useful biomarkers. While current computational methods, such as next generation sequencing (NGS), yield enormous sets of...
2.
Perry S, Buck M, Plummer E, Penmasta R, Batra H, Stavale E, et al.
Antiviral Res
. 2013 Feb;
98(1):35-43.
PMID: 23376501
The aim of the present study was to evaluate the ability of the iminosugar drug UV-4 to provide in vivo protection from lethal dengue virus (DENV) challenge. This study utilized...
3.
Makhluf H, Buck M, King K, Perry S, Henn M, Shresta S
PLoS One
. 2013 Jan;
8(1):e54220.
PMID: 23342105
Dengue virus is the most prevalent mosquito-borne virus worldwide. In this study, we used pyrosequencing to analyze the whole viral genome of two mouse-adapted strains, D2S10 and D2S20, that induce...
4.
Perry S, Buck M, Shresta S
Expert Rev Anti Infect Ther
. 2011 Aug;
9(7):755-7.
PMID: 21810045
No abstract available.
5.
Stein D, Perry S, Buck M, Oehmen C, Fischer M, Poore E, et al.
J Virol
. 2011 Jul;
85(19):10154-66.
PMID: 21795337
The dengue viruses (DENVs) exist as numerous genetic strains that are grouped into four antigenically distinct serotypes. DENV strains from each serotype can cause severe disease and threaten public health...
6.
Perry S, Buck M, Lada S, Schindler C, Shresta S
PLoS Pathog
. 2011 Mar;
7(2):e1001297.
PMID: 21379341
Dengue virus (DENV) is a mosquito-borne flavivirus, and symptoms of infection range from asymptomatic to the severe dengue hemorrhagic fever/dengue shock syndrome (DHF/DSS). High viral loads correlate with disease severity,...
7.
Julander J, Perry S, Shresta S
Antivir Chem Chemother
. 2011 Jan;
21(3):105-16.
PMID: 21233532
There are currently no licensed antivirals available for the treatment of dengue virus (DENV), which causes significant morbidity and mortality throughout tropical areas of the world and is now encroaching...
8.
Perry S, Prestwood T, Lada S, Benedict C, Shresta S
J Virol
. 2009 Jun;
83(16):8276-81.
PMID: 19494017
The role of Cardif-dependent signaling in controlling dengue virus (DENV) infection and regulating type I interferon (IFN) production in vivo was examined in Cardif-deficient mice. DENV RNA levels were significantly...
9.
Perry S, Compton T
J Virol
. 2006 Sep;
80(22):11105-14.
PMID: 16956942
The Kaposi's sarcoma-associated herpesvirus (KSHV) envelope glycoprotein gpK8.1 contributes to cellular attachment through binding cell surface heparan sulfate proteoglycans. By using a soluble recombinant form of gpK8.1, we discovered that...
10.
Boehme K, Singh J, Perry S, Compton T
J Virol
. 2004 Jan;
78(3):1202-11.
PMID: 14722275
Previous studies have shown that human cytomegalovirus (CMV) is a potent elicitor of interferon-stimulated gene (ISG) expression. Induction of the interferon pathway does not require replication-competent virus, and envelope glycoprotein...